PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8798634-8	1996	An AT minor groove-binding drug, distamycin A, disrupted the TBP.TFIIA.DNA complex and restored the EGR1.DNA complex.	stallimycin	33-45	TATA-box binding protein	Homo sapiens	61-64	
10524202-2	1999	Distamycin A inhibits transcription both in vitro and in vivo and can displace from DNA the transcription activator TATA binding protein promoter binding factor (TPBF).	stallimycin	0-12	TATA-box binding protein	Homo sapiens	116-136	
7516181-3	1994	Our results demonstrate that reversible MGBs (DAPI, distamycin A, Hoechst 33258, and netropsin) are effective inhibitors of the formation of DNA/TBP complex and that distamycin A is the most potent (0.16 microM inhibits TBP complex formation by 50%).	stallimycin	52-64	TATA-box binding protein	Homo sapiens	145-148	
7784168-0	1995	Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.	stallimycin	0-12	TATA-box binding protein	Homo sapiens	38-41	
7516181-3	1994	Our results demonstrate that reversible MGBs (DAPI, distamycin A, Hoechst 33258, and netropsin) are effective inhibitors of the formation of DNA/TBP complex and that distamycin A is the most potent (0.16 microM inhibits TBP complex formation by 50%).	stallimycin	166-178	TATA-box binding protein	Homo sapiens	145-148	
7516181-3	1994	Our results demonstrate that reversible MGBs (DAPI, distamycin A, Hoechst 33258, and netropsin) are effective inhibitors of the formation of DNA/TBP complex and that distamycin A is the most potent (0.16 microM inhibits TBP complex formation by 50%).	stallimycin	166-178	TATA-box binding protein	Homo sapiens	220-223	
7516181-4	1994	CC-1065, a drug that covalently binds to DNA in the minor groove, is even more active than distamycin A (0.00085 microM inhibits TBP complex formation by 50%).	stallimycin	91-103	TATA-box binding protein	Homo sapiens	129-132	
7516181-7	1994	In the presence of TFIIA, a factor that enhances TBP association with DNA, greater drug concentrations (distamycin A and CC-1065, respectively) are needed to disrupt a preformed complex of DNA/TBP/TFIIA.	stallimycin	104-116	TATA-box binding protein	Homo sapiens	49-52	
7516181-7	1994	In the presence of TFIIA, a factor that enhances TBP association with DNA, greater drug concentrations (distamycin A and CC-1065, respectively) are needed to disrupt a preformed complex of DNA/TBP/TFIIA.	stallimycin	104-116	TATA-box binding protein	Homo sapiens	193-196